Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1

Cell Growth and Differentiation

Volumn 10, Issue 12, 1999, Pages 785-796

  Quéva, Christophe ^a,b   McArthur, Grant A ^a   Ramos, Leni Sue ^a   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; M PROTEIN; PROTEIN MAD1; PROTEIN P130; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DWARFISM; ENZYME ACTIVITY; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; DWARFISM; EMBRYO LOSS; FIBROBLASTS; GENE EXPRESSION; HELIX-LOOP-HELIX MOTIFS; HEMATOPOIETIC STEM CELLS; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PHENOTYPE; REPRESSOR PROTEINS; SMAD PROTEINS; TRANS-ACTIVATORS;

ANIMALIA; MUS MUSCULUS;

EID: 0343776169     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Raff, M. C. Size control: the regulation of cell numbers in animal development. Cell, 86: 173-175, 1996.
2. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., and Roberts, J. M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85: 733-744, 1996.
3. Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Mayday, A. C., Frohman, L. A., and Koff, A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell, 85: 721-732, 1996.
4. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., and Nakayama, K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
5. Ophascharoensuk, V., Fero, M. L., Hughes, J., Roberts, J. M., and Shankland, S. J. The Cyclin-Dependent Kinase Inhibitor P27(Kip1) Safeguards Against Inflammatory Injury. Nat. Med., 4: 575-580, 1998.
6. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
7. Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., and Kemp, C. J. The murine gene P27(Kip1) is haplo-insufficient for tumour suppression. Nature (Lond.), 396: 177-180, 1998.
8. Bartek, J., Bartkova, J., and Lukas, J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res., 237: 1-6, 1997.
9. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev., 12: 2245-2262, 1998.
10. Mulligan, G., and Jacks, T. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet., 14: 223-229, 1998.
11. Nevins, J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ., 9: 585-593, 1998.
12. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
13. Blackwood, E. M., and Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (Washington DC), 251: 1211-1217, 1991.
14. Ayer, D. E., Kretzner, L., and Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72: 211-222, 1993.
15. Hurlin, P. J., Queva, C., Koskinen, P. J., Steingrimsson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A., and Eisenman, R. N. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J., 14: 5646-5659, 1995.
16. Hurlin, P. J., Queva, C., and Eisenman, R. N. Mnt: a novel Max-interacting protein and Myc antagonist. Curr. Top. Microbiol. Immunol., 224: 115-121, 1997.
17. Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., Brent, R., Ballabio, A., and Carrozzo, R. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16: 2892-2906, 1997.
18. Zervos, A. S., Gyuris, J., and Brent, R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72: 223-232, 1993.
19. Grandori, C., and Eisenman, R. N. Myc target genes. Trends Biochem. Sci., 22: 177-181, 1997.
20. Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., and Land, H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (Lond.), 359: 423-426, 1992.
21. Kretzner, L., Blackwood, E. M., and Eisenman, R. N. Myc, and Max proteins possess distinct transcriptional activities. Nature (Lond.), 359: 426-429, 1992.
22. Amin, C., Wagner, A. J., and Hay, N. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol., 13: 383-390, 1993.
23. Li, L. H., Nerlov, C., Prendergast, G., MacGregor, D., and Ziff, E. B. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J., 73: 4070-4079, 1994.
24. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L., and Ayer, D. E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 89, 341-347, 1997.
25. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E., and Eisenman, R. N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 89: 349-356, 1997.
26. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature (Lond.), 389: 349-352, 1997.
27. Pazin, M. J., and Kadonaga, J. T. What's up and down with histone deacetylation and transcription? Cell, 89: 325-328, 1997.
28. Schreiber-Agus, N., Alland, L., Muhle, R., Gottz, J., Chen, K., Stevens, L., Stein, D., and DePinho, R. A. A biochemical and biological analysis of Myc superfamily interactions. Curr. Top. Microbiol. Immunol., 224: 159-168, 1997.
29. Wolffe, A. P. Transcriptional control. Sinful repression. Nature (Lond.), 387: 16-17, 1997.
30. Quéva, C., Hurlin, P. J., Foley, K. P., and Eisenman, R. N. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene, 16: 967-977, 1998.
31. Eilers, M., Schirm, S., and Bishop, J. M. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J., 10: 133-141, 1991.
32. Roussel, M. F., Cleveland, J. L., Shurtleff, S. A., and Sherr, C. J. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signaling. Nature (Lond.), 353: 361-363, 1991.
33. Askew, D. S., Ashmun, R. A., Simmons, B. C., and Cleveland, J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene, 6: 1915-1922, 1991.
34. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
35. Freytag, S. O. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol. Cell. Biol., 8: 1614-1624, 1988.
36. Langdon, W. Y., Harris, A. W., Cory, S., and Adams, J. M. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell, 47: 11-18, 1986.
37. Heikkila, R., Schwab, G., Wickstrom, E., Loke, S. L., Pluznik, D. H., Watt, R., and Neckers, L. M. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (Lond.), 328: 445-449, 1987.
38. Mateyak, M. K., Obaya, A. J., Adachi, S., and Sedivy, J. M. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ., 8: 1039-1048, 1997.
39. Morgenbesser, S. D., and DePinho, R. A. Use of transgenic mice to study Myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol., 5: 21-36, 1994.
40. Ayer, D. E., and Eisenman, R. N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev., 7: 2110-2119, 1993.
41. Hurlin, P. J., Ayer, D. E., Grandori, C., and Eisenman, R. N. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harbor Symp. Quant. Biol., 59: 109-116, 1994.
42. Larsson, L. G., Pettersson, M., Oberg, F., Nilsson, K., and Luscher, B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene, 9: 1247-1252, 1994.
43. Chin, L., Schreiber-Agus, N., Pellicer, I., Chen, K., Lee, H. W., Dudast, M., Cordon-Cardo, C., and DePinho, R. A. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sci. USA, 92: 8488-8492, 1995.
44. Delgado, M. D., Lerga, A., Canelles, M., Gomez-Casares, M. T., and Leon, J. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene, 10: 1659-1665, 1995.
45. Hurlin, P. J., Foley, K. P., Ayer, D. E., Eisenman, R. N., Hanahan, D., and Arbeit, J. M. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene, 11: 2487-2501, 1995.
46. Västrik, I., Kaipainen, A., Pentillä, T-L., Lymboussakis, A., Alitalo, R., Parvinen, M., and Alitalo, K. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol., 128: 1197-1208: 1995.
47. Cultraro, C. M., Bino, T., and Segal, S. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol. Cell. Biol., 17: 2353-2359, 1997.
48. Cerni, C., Bousset, K., Seelos, C., Burkhardt, H., Henriksson, M., and Luscher, B. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene, 11: 587-596, 1995.
49. Chen, J., Willingham, T., Margraf, L. R., Schreiber-Agus, N., DePinho, R. A., and Nisen, P. D. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat. Med., 1: 638-643, 1995.
50. Koskinen, P. J., Ayer, D. E., and Eisenman, R. N. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth & Differ., 6: 623-629, 1995.
51. Lahoz, E. G., Xu, L., Schreiber-Agus, N., and DePinho, R. A. Suppression of myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl. Acad. Sci. USA, 91: 5503-5507, 1994.
52. Roussel, M. F., Ashmun, R. A., Sherr, C. J., Eisenman, R. N., and Ayer, D. E. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol., 16: 2796-2801, 1996.
53. Wechsler, D. S., Shelly, C. A., Petroff, C. A., and Dang, C. V. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res., 57: 4905-4912, 1997.
54. Foley, K. P., McArthur, G. A., Queva, C., Hurlin, P. J., Soriano, P., and Eisenman, R. N. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J., 17: 774-785, 1998.
55. Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Jr., Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H-W., and dePinho, R. A. Role of Mxi1 in aging organ systems and the regulation of normal and neoplastic growth. Nature (Lond.), 393: 483-487, 1998.
56. Perry, W. L. I., Hustad, C. M., Swing, D. A., Jenkins, N. A., and Copeland, N. G. A transgenic mouse assay for agouti protein activity. Genetics, 140: 267-274, 1995.
57. Metcalf, D. The Hematopoietic Colony Stimulating Factors. Amsterdam: Elsevier, 1984.
58. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
59. Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., and Eilers, M. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
60. Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Muller, R., Ansorge, W., and Eilers, M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J., 15: 3065-3076, 1996.
61. Galaktionov, K., Chen, X., and Beach, D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382: 511-517, 1996.
62. Smith, E. J., Leone, G., and R. N. J. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ., 9: 297-303, 1998.
63. McArthur, G. A., Laherty, C. D., Queva, C., Hurlin, P. J., Loo, L. L. J., Grandori, C., Gallant, P., Shiio, Y., Hokanson, W. C., Bush, A. C., Cheng, P. F., Lawrence, Q., Pulverer, B., Koskinen, P., Foley, K. P., Ayer D, E., and Eisenman, R. N. The Mad protein family links transcriptional repression to cell differentiation. Cold Spring Harbor Symp. Quant. Biol., 63: 423-433: 1998.
64. Behringer, R. R., Mathews, L. S., Palmiter, R. D., and Brinster, R. L. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes & Development, 2: 453-461, 1988.
65. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72, 1993.
66. Voss, J. W., and Rosenfeld, M. G. Anterior pituitary development: short tales from dwarf mice. Cell, 70: 527-530, 1992.
67. Bignon, Y. J., Chen, Y., Chang, C. Y., Riley, D. J., Windle, J. J., Mellon, P. L., and Lee, W. H. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev., 7: 1654-1662, 1993.
68. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9: 2364-2372, 1995.
69. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazelli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1995.
70. Gudas, J. M., Payton, M., Thukral, S., Chen, E., Bass, M., Robinson, M. O., and Coats, S. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol. Cell. Biol., 19: 612-622, 1999.
71. Lauper, N., Beck, A. R., Cariou, S., Richman, L., Hofmann, K., Reith, W., Slingerland, J. M., and Amati, B. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene, 17: 2637-2643, 1998.
72. Zariwala, M., Liu, J., and Xiong, Y. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene, 17: 2787-2798, 1998.
73. Zhao, H., and Xu, Y. H. Mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells. Cell Res. 9: 51-59, 1999.
74. Iavarone, A., and Massagué, J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF? in cells lacking the CDK inhibitor p15. Nature (Lond.), 387: 417-422, 1997.
75. Alevizopoulos, K., Vlach, J., Hennecke, S., and Amati, B. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J., 76: 5322-5333, 1997.
76. Berns, K., Hijmans, E. M., and Bernards, R. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene, 75: 1347-1356, 1997.
77. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., and Eilers, M. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15: 2561-2576, 1997.
78. Perez-Roger, I., Solomon, D. L., Sewing, A., and Land, H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene, 14: 2373-2381, 1997.
79. Vlach, J., Hennecke, S., and Amati, B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J., 16: 5334-5344, 1997.
80. Mateyak, M. K., Obaya, A. J., and Sedivy, J. M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol., 19: 4672-4683, 1999.
81. Wu, S., Pena, A., Korcz, A., Soprano, D. R., and Soprano, K. J. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene, 12: 621-629, 1996.
82. Boyd, K. E., and Famham, P. J. Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol. Cell. Biol., 17: 2529-2537, 1997.
83. Desbarats, L., Gaubatz, S., and Eilers, M. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev., 10: 447-460, 1996.
84. Hogan, B., Beddington, R., Costantini, F., and Lacy, E. Manipulating the mouse embryo, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1994.
85. Clurman, B. E., Sheaff, R., Thress, K., Groudine, M., and Roberts, J. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by CDK2 binding and cyclin phosphorylation. Genes Dev., 70: 1979-1990, 1996.
86. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.